Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetic Priming to Enhance Cognitive Training Gains and Neuroplasticity in Middle-age and Older Adults With Mood or Schizophrenia Spectrum Disorders (EPIC)

NCT07404085 is registered in ClinicalTrials.gov with Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital as lead sponsor.

NCT NCT07404085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07404085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetic Priming to Enhance Cognitive Training Gains and Neuroplasticity in Middle-age and Older Adults With Mood or Schizophrenia Spectrum Disorders (EPIC)
Lead sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 14, 2025
Completion date
July 1, 2028
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder (bd), cognitive impairment, depression - major depressive disorder, schizophrenia disorders